PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
24.38%
Revenue growth 1.25-1.5x MAXN's 18.85%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
102.35%
Gross profit growth at 50-75% of MAXN's 159.45%. Martin Whitman would question if cost structure or brand is lagging.
186.59%
EBIT growth above 1.5x MAXN's 34.91%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
1259.49%
Operating income growth above 1.5x MAXN's 34.91%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
824.29%
Net income growth above 1.5x MAXN's 105.10%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
830.77%
EPS growth above 1.5x MAXN's 114.23%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
766.67%
Diluted EPS growth above 1.5x MAXN's 114.23%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.09%
Slight or no buybacks while MAXN is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.81%
Slight or no buyback while MAXN is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
134.63%
Positive OCF growth while MAXN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
125.80%
Positive FCF growth while MAXN is negative. John Neff would see a strong competitive edge in net cash generation.
-79.51%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-27.17%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-57.44%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-96.52%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
104.06%
Positive OCF/share growth while MAXN is negative. John Neff might see a comparative advantage in operational cash viability.
-74.13%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
52.21%
Below 50% of MAXN's 113.06%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
357.82%
5Y net income/share CAGR above 1.5x MAXN's 113.06%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
159.44%
3Y net income/share CAGR 1.25-1.5x MAXN's 113.06%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
-86.30%
Negative equity/share CAGR over 10 years while MAXN stands at 44.58%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-77.75%
Negative 5Y equity/share growth while MAXN is at 44.58%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
131.73%
3Y equity/share CAGR above 1.5x MAXN's 44.58%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while MAXN invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-12.53%
Firm’s AR is declining while MAXN shows 38.69%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
18.21%
We show growth while MAXN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
13.60%
Positive asset growth while MAXN is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5847.50%
Positive BV/share change while MAXN is negative. John Neff sees a clear edge over a competitor losing equity.
-26.60%
We’re deleveraging while MAXN stands at 8.99%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-38.72%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
48.07%
SG&A growth well above MAXN's 41.20%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.